{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:19:44Z","timestamp":1792091984933,"version":"4.4.0"},"reference-count":35,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20250307"],"award-info":[{"award-number":["20250307"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Science Progress"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the physical and chemical stability of cefminox sodium, cefuroxime sodium, cefoxitin sodium, ceftizoxime sodium, cefmetazole sodium, ceftazidime and cefamandole nafate when continuously infused with 0.9% sodium chloride (NS) and 5% glucose (GS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seven cephalosporin antibiotics were reconstituted in 50 and 100\u2005mL of NS and GS, and stored at room temperature. Samples were collected at 0, 2, 4, 8, and 24 hours to evaluate changes in appearance, pH, insoluble particle count, and drug content.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The admixture solutions of cefuroxime with both solvents turned yellow at 8 hours. The relative percentage content of the low-concentration group in NS dropped to 82.97% at 24 hours. When cefamandole nafate was admixed with NS, contents of both high and low concentrations dropped below 90% at 8 hours and below 60% at 24 hours. The pH change of the high-concentration group exceeded 1.0\u2005pH unit at 24 hours. For cefoxitin sodium, the pH change of all concentration groups admixed with both solvents exceeded 1.0\u2005pH unit at 24 hours. The high-concentration group in NS declined to 87.72%. The admixture solutions of cefminox with both solvents showed slight discoloration at 24 hours. When cefminox was admixed with GS, the contents of both concentration groups dropped below 90% at 2 hours. All other drug\u2013solvent\u2013concentration combinations had all indicators within the specified limits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>When admixed with NS, cefmetazole, ceftazidime, and ceftizoxime are stable for 24 hours continuous infusion; cefoxitin and cefminox for up to 8 hours; and cefuroxime and cefamandole nafate for 4 hours. When admixed with GS, cefmetazole, ceftazidime, and ceftizoxime are stable for 24 hours; cefoxitin for up to 8 hours; cefuroxime for 4 hours; and cefminox has a stability period of less than 2 hours, so GS is not recommended as it is continuous infusion solvent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00368504251397429","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T18:01:01Z","timestamp":1763575261000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Compatibility and stability of seven selected cephalosporin antibiotics during extended infusion"],"prefix":"10.1177","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7599-8997","authenticated-orcid":false,"given":"Liting","family":"Zhang","sequence":"first","affiliation":[{"name":"Hebei Medical University"},{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3914-5684","authenticated-orcid":false,"given":"Yao","family":"Wang","sequence":"additional","affiliation":[{"name":"Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4844-018X","authenticated-orcid":false,"given":"Liju","family":"Fan","sequence":"additional","affiliation":[{"name":"Hebei Medical University"},{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8553-4230","authenticated-orcid":false,"given":"Xinjian","family":"Guo","sequence":"additional","affiliation":[{"name":"Hebei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6899-9963","authenticated-orcid":false,"given":"Jing","family":"An","sequence":"additional","affiliation":[{"name":"Hebei Medical University"},{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-4970","authenticated-orcid":false,"given":"Zhanjun","family":"Dong","sequence":"additional","affiliation":[{"name":"Hebei Medical University"},{"name":"Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100249"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0420-1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01893-6"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc13134"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2024.2324940"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3080"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/nicc.12754"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1360\/SSV-2021-0180"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-021-04165-x"},{"key":"e_1_3_2_11_2","article-title":"In sepsis, continuous and intermittent infusion of \u03b2-lactam antibiotics did not differ for mortality at 90 d","volume":"177","author":"Walker MK","year":"2024","unstructured":"Walker MK, Strich JR. In sepsis, continuous and intermittent infusion of \u03b2-lactam antibiotics did not differ for mortality at 90 d. Ann Intern Med 2024; 177: JC102.","journal-title":"Ann Intern Med"},{"key":"e_1_3_2_12_2","first-page":"1298","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"64","author":"Kalil AC","year":"2017","unstructured":"Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2017; 64: 1298.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2844"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30615-1"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.027"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.22146\/ijp.2262"},{"key":"e_1_3_2_17_2","first-page":"875","article-title":"Stability of cefamandole nafate and cefoxitin sodium solutions","volume":"38","author":"Das Gupta V","year":"1981","unstructured":"Das Gupta V, Stewart KR. Stability of cefamandole nafate and cefoxitin sodium solutions. Am J Hosp Pharm 1981; 38: 875\u2013879.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_2_18_2","first-page":"33","article-title":"Cefoxitin sodium compatibility with intravenous infusions and additives","volume":"36","author":"O'Brien MJ","year":"1979","unstructured":"O'Brien MJ, Portnoff JB, Cohen EM. Cefoxitin sodium compatibility with intravenous infusions and additives. Am J Hosp Pharm 1979; 36: 33\u201338.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxy035"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.1996.tb00020.x"},{"key":"e_1_3_2_21_2","author":"Chinese Pharmacopoeia Commission","year":"2020","unstructured":"Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. 2020.","journal-title":"Pharmacopoeia of the People's Republic of China"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03854-7"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2024-004450"},{"key":"e_1_3_2_24_2","unstructured":"Guidance for Industry: Drug Stability Guidelines. U.S. Department of health and human services food and drug administration. Silver Spring 2008."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-023-01716-7"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.02.002"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/vde.12997"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220918025"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.116876"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2023-003855"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmy101"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77334-5"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01174-24"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(94)80016-2"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/4.suppl_B.69"},{"key":"e_1_3_2_36_2","first-page":"310","article-title":"Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use","volume":"7","author":"Gupta VD","year":"2003","unstructured":"Gupta VD. Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Int J Pharm Compd 2003; 7: 310\u2013312.","journal-title":"Int J Pharm Compd"}],"container-title":["Science Progress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00368504251397429","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00368504251397429","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00368504251397429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:18:50Z","timestamp":1777634330000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00368504251397429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/00368504251397429"],"URL":"https:\/\/doi.org\/10.1177\/00368504251397429","relation":{},"ISSN":["0036-8504","2047-7163"],"issn-type":[{"value":"0036-8504","type":"print"},{"value":"2047-7163","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"article-number":"00368504251397429"}}